Ask for the whole bill.
For tirzepatide (Mounjaro, Zepbound), ask about the medicine, the care visits and any tests. Keep those questions together when comparing options.
What might the medicine cost without insurance?
Recorded September 26, 2026, the maker’s monthly cash prices for Zepbound ran from $299 up to $699. This was for vials, small medicine bottles, or the KwikPen, an injection pen containing several doses.
Maker’s monthly cash range
$299–$699
This range was recorded September 26, 2026 for Zepbound medicine bottles and the KwikPen injection pen.
The exact price depends on the strength and the timing of the next purchase. Strength here means how much medicine each dose contains.
The maker’s offer priced a monthly supply at $449 for these strengths: 7.5 mg strength, 10 mg strength, 12.5 mg strength and 15 mg strength. This required buying the next supply within 45 days of the last delivery. Here, mg means milligrams, a unit for measuring the amount of medicine.
Without that offer, the monthly price was $499 at 7.5 mg and $699 at 10 mg, 12.5 mg or 15 mg. The regular monthly prices were $299 at 2.5 mg and $399 at 5 mg.
These amounts name the price options. Your prescriber decides which strength fits your care.
The recorded offer terms run through December 31, 2026, so ask for the terms that apply when paying.
Ask for the medicine’s exact form, the quoted supply and the next refill’s price. A starting figure is not a quote for your whole plan.
See the price notesDoes insurance pay?
Ask the insurance plan about the proposed product by name and the health condition it is meant to treat. Request the answer in writing if possible.
Medicare drug-plan coverage was possible as of September 26, 2026 for two uses: treating type 2 diabetes with Mounjaro, or treating moderate to severe obstructive sleep apnea with Zepbound when obesity is also present.
With obstructive sleep apnea, a blocked airway causes repeated pauses or shallow breathing while asleep.
Coverage is possible, but not promised. The medicine must be on the plan’s list, and the plan must approve the request before it pays.
Ask separately about Medicare’s weight programme.
CMS, the agency running Medicare, describes its temporary Medicare GLP-1 Bridge as a route for people who meet its rules and have Part D, Medicare’s prescription-drug coverage.
GLP-1 is the name of a hormone, a chemical message from the gut that helps control hunger and blood sugar. The programme name refers to medicines that act like this message.
Eligible Medicare Bridge patients
$50 per month
CMS’s terms checked September 26, 2026 set a $50 copay, the amount the patient pays, for a monthly supply. The programme’s dates are July 1, 2026 for its start and December 31, 2027 for its end.
As of September 26, 2026, the programme included only the Zepbound KwikPen for tirzepatide; single-dose pens and vials were excluded.
CMS’s terms checked September 26, 2026 require a prescription, approval before payment and a qualifying Medicare drug plan. You must be at least 18. The age and health rules are judged from when treatment with these medicines began.
The weight rules use BMI. This number is worked out from your height and weight. Ask the prescriber to calculate it and see which of these routes fits:
- BMI at or above 35.
- BMI of 30 or more, plus one of these: a type of heart failure called heart failure with preserved ejection fraction; high blood pressure above the limits below despite two medicines for it; or kidney disease graded stage 3a or later.
- BMI of 27 or more, with one of these: pre-diabetes, when blood sugar is higher than normal without reaching the diabetes range; a past heart attack or stroke; or symptoms from narrowed arteries, the blood vessels carrying blood to the arms or legs.
For the blood-pressure route, CMS sets the limit above 140 for the top reading or above 90 for the bottom reading, measured in mm Hg, the usual blood-pressure unit. The pressure must remain above that limit despite two blood-pressure medicines.
Ask whether your heart diagnosis or kidney results match the exact medical terms in these rules. Weight alone does not tell everyone whether they qualify.
CMS also requires ongoing changes to food and activity. You cannot use the 2026 Bridge if your GLP-1 medicine was paid for by Part D during 2026. As of September 26, 2026, CMS had not set the earlier-use rule for 2027.
Under CMS’s terms checked September 26, 2026, ordinary Part D is the route for people with type 2 diabetes. It is also the route for people with obstructive sleep apnea that is moderate to severe.
This also applies to a liver illness called MASH when there is moderate to advanced liver scarring but no cirrhosis, meaning severe lasting liver scarring. A fatty liver diagnosis by itself does not always exclude someone from the Bridge. A prescription to lower the risk of serious heart or blood-vessel problems also goes through ordinary Part D.
Ask the prescriber to check those diagnoses in your health record. Ask your drug plan whether your type of plan allows the Bridge.
The yearly Part D cap limits what you pay for medicines covered through ordinary Part D, rather than the whole medicine bill. That limit is $2,100 in 2026 and $2,400 in 2027.
Once your counted payments reach that limit, you owe no more for those covered Part D medicines for the rest of that year. CMS says none of your $50 Bridge payment counts toward the limit. Medicare’s extra help with drug costs for people on low incomes does not reduce that payment.
Ask your plan which payments count toward your yearly limit and what it pays once you reach that limit. Keep the Bridge payment separate when checking the answer.
Read Medicare’s consumer explanationRead CMS’s full eligibility termsA savings card is another question.
The maker’s savings-card rules checked September 26, 2026 require insurance from a private plan or workplace. People with Medicare, Medicaid or military coverage are excluded.
Being excluded from a savings card does not automatically exclude someone from a maker’s cash price.
What is added to the medicine price?
A review of six national online weight-care services’ advertised prices on September 26, 2026 found that five charged a monthly membership and one charged per visit. The five memberships charged for medicine separately. This was a small review of adverts, not a price quote for your care.
The standard monthly membership prices shown in that review ranged from $19.99 to $149. Cash visit prices ranged from $38 to $129. These were advertised care charges; the medicine was a separate cost for the memberships.
Ask for the regular bill after any opening offer. Then ask what happens to charges if no prescription is given or the care plan changes.
- What does the visit or membership include?
- Are the medicine and delivery included?
- Are any tests billed separately?
- What will the bill be after the first offer ends?
- How do I cancel, and when do charges stop?
Write each answer beside its charge. Bring the total back to the prescriber if paying for the plan would be hard to sustain.